cbdMD™ Makes History Becoming the First CBD Brand to Achieve 3 NSF’s Certified for Sport® Certifications
08 3월 2023 - 2:33AM
Business Wire
New suite of products allows professionals from all walks of
life to add CBD to their regimen without fear of failing a drug
test for THC.
cbdMD, Inc. (NYSE American: YCBD and YCBDpA), one of the
nation's leading, highly trusted, and widely recognized CBD
companies, today announces the release of the third product in its
comprehensive NSF Certified for Sport® line of CBD products:
cbdMD’s 1500 mg Tropical Mix Gummies with 50 mg of CBD per serving.
The Company now has the largest product offering of Certified for
Sport® products in the market with its cbdMD PM softgels, its
general wellness 1500 mg softgels, and now its general wellness
1500 mg gummies to provide a full suite of solutions for consumers
looking to have the cleanest products without fear of failing a
drug test. Athletes at the highest levels have already begun their
wellness journey confidently using cbdMD’s newly approved NSF
Certified for Sport® as the brand leader they trust.
cbdMD continues to lead the market with its value proposition
with Certified for Sport® products that offer the highest potency
of CBD per serving at the lowest prices as compared to the
competition. Not only does cbdMD have the largest product offering,
the highest per serving milligrams, and the lowest prices, but
independent testing shows that the cbdMD NSF Certified for Sport
products contain significantly less THC than many of the other NSF
for Sport products on the market1.
“Having the third product in our Certified for Sport line
demonstrates our commitment to leading the industry with the most
options for products that can be consumed without fear of failing a
drug test. These products are not just for athletes,” stated
Shannon Charles, cbdMD’s Chief Marketing Officer. “First
responders, doctors, nurses, educators, tradespeople, and anyone
subject to workplace drug testing can rest assured they will not
fail when taking the cbdMD Certified for Sport® products.” She went
on to say, “As we lead by example, it’s a really proud moment as
the first CBD company with a Certified® for Sport® product on the
market, and the company with the largest catalog of Certified for
Sport® products. We don’t need a high-profile sponsorship deal with
a major sports league to show the public why we are the best
choice. With the most options available in the market, at the best
value per milligram of CBD, we are confident consumers will make
the right choice and choose cbdMD when it comes to their
wellbeing.”
_____________________________
1 based on comparison of publicly
available Certificates of Analysis as of March 6, 2022
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and
recognized hemp-derived cannabidiol (CBD) brands with a
comprehensive line of U.S. produced, THC-free1 CBD products as well
as Full Spectrum and Delta 9 THC products. The cbdMD brand
currently includes high-quality, premium CBD products including
tinctures, gummies, topicals, capsules, sleep aids and more. The
Company's Paw CBD brand includes formulated pet products including
tinctures, chews and topicals in varying strengths. To learn more
about cbdMD and the complete line of products, please visit
www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one
of the thousands of retail outlets that carry cbdMD products.
Forward-Looking Statements
This press release contains certain forward-looking statements
that are based upon current expectations and involve certain risks
and uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can
be identified using words such as ''should,'' ''may,'' ''intends,''
''anticipates,'' ''believes,'' ''estimates,'' ''projects,''
''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These
forward-looking statements are not guarantees of future performance
and are subject to risks, uncertainties, and other factors, some of
which are beyond our control and difficult to predict. You are
urged to carefully review and consider any cautionary statements,
including but not limited to expectations on our clinical studies,
and other disclosures, including the statements made under the
heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K
for the fiscal year ended September 30, 2022 as filed with the
Securities and Exchange Commission (the "SEC") on December 15, 2022
and as amended on December 20, 2022 and our other filings with the
SEC. All forward-looking statements involve significant risks and
uncertainties that could cause actual results to differ materially
from those in the forward-looking statements, many of which are
generally outside the control of cbdMD, Inc. and are difficult to
predict. cbdMD, Inc. does not undertake any duty to update any
forward-looking statements except as may be required by law. The
information which appears on our websites and our social media
platforms, including, but not limited to, Instagram and Facebook,
is not part of this press release.
1 THC-free is defined as below the level of detection using
validated scientific analytical tools.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230307005901/en/
cbdMD, Inc. Ronan Kennedy, CFO +1 (704) 445-3064
IR@cbdmd.com
cbdMD (AMEX:YCBD)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
cbdMD (AMEX:YCBD)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024